Prophylactic activity of atovaquone against Plasmodium falciparum in humans

American Journal of Tropical Medicine and Hygiene

Volumn 60, Issue 5, 1999, Pages 831-836

  Shapiro, Theresa A ^a   Ranasinha, Channa D ^b   Kumar, Nirbhay ^c   Barditch Crovo, Patricia ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Courtlands ^*  (United Kingdom)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATOVAQUONE; ATOVAQUONE PLUS PROGUANIL; PLACEBO;

ADULT; ANOPHELES STEPHENSI; ANTIBIOTIC PROPHYLAXIS; ANTIPROTOZOAL ACTIVITY; AREA UNDER THE CURVE; ARTICLE; CHILL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FEVER; HEADACHE; HUMAN; HUMAN EXPERIMENT; INSECT BITE; LEUKOPENIA; MALARIA FALCIPARUM; MALE; MYALGIA; NORMAL HUMAN; PARASITEMIA; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTOPENIA;

EID: 0032955901     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.1999.60.831     Document Type: Article

References (38)

1. Lobel HO, Campbell CC, Pappaioanou M, Huong AY, 1987. Use of prophylaxis for malaria by American travelers to Africa and Haiti. JAMA 257: 2626-2627.
2. Steffen R, 1997. The epidemiology of travel-related health problems. Clift S, Grabowski P, eds. Tourism and Health: Risk, Research and Responses. London: Pinter, 25-37.
3. Olliaro P, Cattani J, Wirth D, 1996. Malaria, the submerged disease. JAMA 275: 230-233.
4. Fry M, Pudney M, 1992. Site of action of the antimalarial hydroxynaphthoquinone, 2-[trans-4-(4′-chlorophenyl)cyclohexyl] -3-hydroxy-1,4-naphthoquinone (566C80). Biochem Pharmacol 43: 1545-1553.
5. Hammond DJ, Burchell JR, Pudney M, 1985. Inhibition of pyrimidine biosynthesis de nova in Plasmadium falciparum by 2-(4-t-butylcyclohexyl)-3-hydroxy-1,4-naphthoquinone in vitro. Mol Biochem Parasitol 14: 97-109.
6. Srivastava IK, Rottenberg H, Vaidya AB, 1997. Atovaquone, a broad spectrum antiparasitic drug, collapses mitochondrial membrane potential in a malarial parasite. J Biol Chem 272: 3961-3966.
7. Basco LK, Ramiliarisoa O, LeBras J, 1995. In vitro activity of atovaquone against the African isolates and clones of Plasmodium falciparum. Am J Trop Med Hyg 53: 388-391.
8. Gay F, Bustos D, Traore B, Jardinel C, Southammavong M, Ciceron L, Danis MM, 1997. In vitro response of Plasmodium falciparum to atovaquone and correlation with other antimalarials: comparison between African and Asian strains. Am J Trop Med Hvg 56: 315-317.
9. Hudson AT, Dickins M, Ginger CD, Gutteridge WE, Holdich T, Hutchinson DBA, Pudney M, Randall AW, Latter VS, 1991. 566C80: a potent broad spectrum anti-infective agent with activity against malaria and opportunistic infections in AIDS patients. Drugs Exp Clin Res 17: 427-435.
10. Chiodini PL, Conlon CP, Hutchinson DBA, Farquhar JA, Hall AP, Peto TEA, Birley H, Warrell DA, 1995. Evaluation of atovaquone in the treatment of patients with uncomplicated Plasmodium falciparum malaria. J Antimicrob Chemather 36: 1073-1078.
11. Looareesuwan S, Viravan C, Webster HK, Kyle DE, Hutchinson DB, Canfield CJ. 1996. Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand. Am J Trop Med Hyg 54: 62-66.
12. Canfield CJ, Pudney M, Gutteridge WE, 1995. Interactions of atovaquone with other antimalarial drugs against Plasmodium falciparum in vitro. Exp Parasitai 80: 373-381.
13. de Alencar FE, Cerutti Jr C, Durlacher RR, Boulos M, Alves FP, Milhous W, Pang LW, 1997. Atovaquone and proguanil for the treatment of malaria in Brazil. J Infect Dis 175: 1544-1547.
14. Radloff PD, Philipps J, Nkeyi M, Hutchinson D, Kremsner PG, 1996. Atovaquone and proguanil for Plasmodium falciparum malaria. Lancet 347: 1511-1514.
15. Shanks GD, Gordon DM, Klotz FW, Aleman GM, Oloo AJ, Sadie D, Scott TR, 1998. Efficacy and safety of atovaquone/ proguanil as suppressive prophylaxis for Plasmodium falciparum malaria. Clin Infect Dis 27: 494-499.
16. Lell B, Luckner D, Ndjavé M, Scott T, Kremsner PG, 1998. Randomised placebo-controlled study of atovaquone plus proguanil for malaria prophylaxis in children. Lancet 351: 709-713.
17. Fairley NH, 1946. Researches on paludrine (M.4888) in malaria: an experimental investigation undertaken by the L.H.Q. Medical Research Unit (A.I.F.), Cairns, Australia. Trans R Soc Trop Med Hyg 40: 105-151.
18. Davies CS, Pudney M, Nicholas JC, Sinden RE, 1993. The novel hydroxynaphthoquinone 566C80 inhibits the development of liver stages of Plasmodium berghei cultured in vitro. Parasitology 106: 1-6.
19. Davies CS, Pudney M, Matthews PJ, Sinden RE, 1989. The causal prophylactic activity of the novel hydroxynaphthoquinone 566C80 against Plasmodium berghei infections in rats. Acta Leiden 58: 115-128.
20. Peters W, 1990. The prevention of antimalarial drug resistance. Pharmacol Ther 47: 499-508.
21. 1983. 1983 metropolitan height and weight tables. Stat Bull Metrop Life Found 64: 2-9.
22. Lachin JM, 1981. Introduction to sample size determination and power analysis for clinical trials. Control Clin Trials 2: 93-113.
23. Davis JR, 1994. Laboratory methods for the conduct of experimental malaria challenge of volunteers. Vaccine 12: 321-327.
24. Ponnudurai T, Leeuwenberg ADEM, Meuwissen JHETh, 1981. Chloroquine sensitivity of isolates of Plasmodium falciparum adapted to in vitro culture. Trop Geogr Med 33: 50-54.
25. Posner GH, González L, Cumming JN, Klinedinst D, Shapiro TA, 1997. Synthesis and antimalarial activity of heteroatom-containing bicyclic endoperoxides. Tetrahedron 53: 37-50.
26. Rickman LS, Long GW, Oberst R, Cabanban A, Sangalang R, Smith JI, Chulay JD, Hoffman SL, 1989. Rapid diagnosis of malaria by acridine orange staining of centrifuged parasites. Lancet I: 68-71.
27. Mount DL, Nahlen BL, Patchen LC, Churchill FC, 1989. Adaptations of the Saker-Solomons test: simple, reliable colonmetric field assays for chloroquine and its metabolites in urine. Bull World Health Organ 67: 295-300.
28. Studenberg SD, Long JD, Woolf JH, Bruner CJ, Wilson D, Woolley JL, 1995. A robotics-based liquid chromatographic assay for the measurement of atovaquone in plasma. J Pharm Biomed Anal 13: 1383-1393.
29. Cheng Q, Lawrence G, Reed C, Stowers A, Ranford-Cartwright L, Creasey A, Carter R, Saul A, 1997. Measurement of Plasmodium falciparum growth rates in vivo: a test of malaria vaccines. Am J Trop Med Hyg 57: 495-500.
30. Murphy JR, Baqar S, Davis JR, Herrington DA, Clyde DF, 1989. Evidence for a 6.5-day minimum exoerythrocytic cycle for Plasmodium falciparum in humans and confirmation that immunization with a synthetic peptide representative of a region of the circumsporozoite protein retards infection. J Clin Microbiol 27: 1434-1437.
31. Giles HM, 1993. The malaria parasites. Gilles HM, Warrell DA, eds. Bruce-Chwatt's Essential Malariology. London: Edward Arnold, 12-34.
32. Shortt HE, Fairley NH, Covell G, Shute PG, Garnham PCC, 1951. The pre-erythrocytic stage of Plasmodium falciparum. Trans R Soc Trop Med Hyg 44: 405-419.
33. Collins WE, Warren M, Skinner JC, Chin W, Richardson BB, 1977. Studies on the Santa Lucia (El Salvador) strain of Plasmodium falciparum in Aotus trivirgatus monkeys. J Parasitol 63: 52-56.
34. Church LWP, Le TP, Bryan JP, Gordon DM, Edelman R, Fries L, Davis JR, Herrington DA, Clyde DF, Shmuklarsky MJ, Schneider I, McGovern TW, Chulay JD, Ballou WR, Hoffman SL, 1997. Clinical manifestations of Plasmodium falciparum malaria experimentally induced by mosquito challenge. J Infect Dis 175: 915-920.
35. Coatney GR, Cooper WC, Young MD, McLendon SB, 1947. Studies in human malaria I. The protective action of sulfadiazine and sulfapyrazine against sporozoite-induced falciparum malaria. Am J Hyg 46: 84-104.
36. Anonymous, 1993. Atovaquone for Pneumocystis carinii pneumonia. Med Lett 35: 28-29.
37. Rolan PE, Mercer AJ, Tate E, Benjamin I, Posner J, 1997. Disposition of atovaquone in humans. Antimicrob Agents Chemother 41: 1319-1321.
38. Scheibel LW, 1988 Plasmodial metabolism and related organellar function during various stages of the life-cycle: carbohydrates. Wernsdorfer WH, McGregor I, eds, Malaria: Principles and Practice of Malariology. Edinburgh: Churchill Livingstone, 171-217.